M&A Deal Summary

Boston Scientific Acquires Silk Road Medical

On June 18, 2024, Boston Scientific acquired medical products company Silk Road Medical for 1.3B USD

Acquisition Highlights
  • This is Boston Scientific’s 49th transaction in the Medical Products sector.
  • This is Boston Scientific’s 6th largest (disclosed) transaction.
  • This is Boston Scientific’s 49th transaction in the United States.
  • This is Boston Scientific’s 26th transaction in California.

M&A Deal Summary
Date 2024-06-18
Target Silk Road Medical
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 1.3B USD
Advisor(s) BofA Securities (Financial)
Wilson Sonsini Goodrich & Rosati (Legal)

Target

Silk Road Medical

Sunnyvale, California, United States
Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medial was formed in 2007 and is based in Sunnyvale, California.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 64 of 66
Sector (Medical Products) 49 of 50
Type (Add-on Acquisition) 50 of 51
State (California) 26 of 27
Country (United States) 49 of 51
Year (2024) 2 of 4
Size (of disclosed) 6 of 34
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-08 Axonics

Irvine, California, United States

Axonics is focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. The Axonics product portfolio includes the Axonics R20TM and the Axonics F15TM Systems used to deliver sacral neuromodulation (SNM) therapy. SNM therapy is a minimally invasive procedure used in the treatment of OAB and fecal incontinence. It works by delivering mild electrical pulses to the sacral nerve to restore communication between the brain and the bladder. Axonics was founded in 2013 and is headquartered in Irvine, California.

Buy $3.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-04 Cortex

Menlo Park, California, United States

Cortex is a medical technology company focused on the development of a diagnostic mapping solution which may identify triggers and drivers outside of the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder affecting nearly 38 million people globally. Cortex is based in Menlo Park, California.

Buy -
Mergr

Product

Company

Legal